Atlas Trials

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

Clinical trial NCT01525966 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01525966
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Inflammatory Breast CancerStage IIA Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerTriple-negative Breast CancerStage IIB Breast CancerEstrogen Receptor NegativeProgesterone Receptor NegativeHER2/Neu Negative
Start date
2012-02-15
Primary completion
2019-01-11
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.